Tahsin Khan
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms, Colorectal Cancer Treatments and Studies, Cancer, Hypoxia, and Metabolism, Lung Cancer Research Studies
Most-Cited Works
- → Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers(2012)1,320 cited
- → Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)816 cited
- → A genetic mechanism for Tibetan high-altitude adaptation(2014)430 cited
- → Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1(2013)410 cited
- → Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib(2014)286 cited
- → Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo(2013)115 cited
- → Polymorphism Analysis Reveals Reduced Negative Selection and Elevated Rate of Insertions and Deletions in Intrinsically Disordered Protein Regions(2015)48 cited
- → Differential priority effects impact taxonomy and functionality of host‐associated microbiomes(2022)33 cited
- → Genetic testing for Lynch syndrome in the province of Ontario(2016)15 cited
- → Erratum: Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)15 cited